StonvexLoading…
StonvexStonvexStonvexCore line items from CNEY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-09-30 | Annual 2021 2021-09-30 | Annual 2020 2020-09-30 | Annual 2019 2019-09-30 |
|---|---|---|---|---|
Revenue | $40.21M | $19.85M | $12.48M | $10.89M |
Operating Income | $459.83K | $583.38K | $2.00M | $1.19M |
Net Income | $2.23M | $1.30M | $2.34M | $1.67M |
EPS (Diluted) | $3.09 | $2.56 | $0.23 | $0.17 |
Total Assets | $94.94M | $68.96M | $31.44M | Not available |
Total Liabilities | $31.16M | $6.28M | $8.32M | Not available |
Cash & Equivalents | $18.05M | $190.76K | $1.57M | $1.56M |
Free Cash Flow OCF − CapEx | $-10.01M | $-12.03M | $-1.83M | $-761.83K |
Shares Outstanding | 721.99K | 20.32M | 10.00M | 10.00M |